Page last updated: 2024-08-20

ditiocarb and HIV

ditiocarb has been researched along with HIV in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Delsaux, MC; Lang, JM; Pompidou, A; Sarin, P; Telvi, L1
Choutet, P; Falkenrodt, A; Herviou, L; Kirstetter, M; Lang, JM; Livrozet, JM; Retornaz, G; Touraine, F; Touraine, JL; Trepo, C1

Trials

1 trial(s) available for ditiocarb and HIV

ArticleYear
Randomised, double-blind, placebo-controlled trial of ditiocarb sodium ('Imuthiol') in human immunodeficiency virus infection.
    Lancet (London, England), 1988, Sep-24, Volume: 2, Issue:8613

    Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Clinical Trials as Topic; Ditiocarb; Double-Blind Method; Drug Administration Schedule; Drug Evaluation; HIV; HIV Seropositivity; Humans; Leukocyte Count; Lymphocytes; Random Allocation; Skin Tests

1988

Other Studies

1 other study(ies) available for ditiocarb and HIV

ArticleYear
Influence of immunomodulators on T lymphocyte differentiation in ARC patients and resistance to LAV/HTLV III infection.
    Comparative immunology, microbiology and infectious diseases, 1986, Volume: 9, Issue:2-3

    Topics: Adult; AIDS-Related Complex; Ditiocarb; HIV; Humans; Inosine; Inosine Pranobex; Lymphocyte Activation; Male; Middle Aged; T-Lymphocytes

1986